GFAP and depressive symptom measurement: Despite being poorly expressed in the hippocampus of depression rat models, if overexpressed it may decrease the expression of the connective tissue growth factor (CTGF), preventing cell apoptosis of hippocampal neurons, and neuroinflammation while increasing the expression of GFAP, BDNF and other neurotransmitters [122].